"The staff working on this broad agency effort are exceptionally qualified and extremely committed. This initiative is a very complex, long-term effort that calls for collaboration, continuing support, and the ability to do things a little differently."
-- Luciana Borio, MD, Assistant Commissioner for Counterterrorism Policy; Director, OCET; and Acting Deputy Chief Scientist
Scientific and professional staff from FDA medical product centers and the Office of Counterterrorism and Emerging Threats (OCET) support the Medical Countermeasures Initiative (MCMi). We invite you to meet some of the people who help the MCMi protect national health and security.
- Luciana Borio, MD, Assistant Commissioner for Counterterrorism Policy and Acting Deputy Chief Scientist
Director, Office of Counterterrorism and Emerging Threats (OCET), Office of the Chief Scientist (OCS)
- William Dickerson, MD, Radiation Oncologist, Medical Reviewer
Division of Medical Imaging Products, Center for Drug Evaluation and Research (CDER)
- Sally Hojvat, MSc, PhD, Director of the Division of Microbiology Devices
Office of In-vitro Diagnostic (IVD) Device Evaluation and Safety , Center for Devices and Radiological Health (CDRH)
- Suzanne Schwartz, Director of Emergency Preparedness/Operations and Medical Countermeasures
Office of the Center Director, Center for Devices and Radiological Health (CDRH)
Speaker Requests: To request an FDA speaker for your MCM-related event, please contact AskMCMi@fda.hhs.gov. At least 60 days advance notice is recommended.